Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord (central nervous system).
It is a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure.
Often MS can cause permanent disability and even death. It is unknown what exactly causes MS. The most common thought is that a virus or gene defect- or both- are to blame.
In a recent study from Harvard University, scientists found that MS is likely caused by infection with the Epstein-Barr virus (EBV).
The hypothesis that EBV causes MS has been examined for several years, but this is the first study providing compelling evidence of causality.
It suggests that most MS cases could be prevented by stopping EBV infection and that targeting EBV could lead to the discovery of a cure for MS.
MS is a chronic inflammatory disease of the central nervous system that attacks the myelin sheaths protecting neurons in the brain and spinal cord.
Its cause is not known, yet one of the top suspects is EBV, a herpes virus that can cause infectious mononucleosis and establishes a latent, lifelong infection of the host.
Establishing a causal relationship between the virus and the disease has been difficult because EBV infects approximately 95% of adults, MS is a relatively rare disease, and the onset of MS symptoms begins about ten years after EBV infection.
The researchers conducted a study among more than 10 million young adults on active duty in the U.S. military and identified 955 who was diagnosed with MS during their period of service.
In the study, researchers analyzed blood samples taken biennially by the military and determined the soldiers’ EBV status at the time of the first sample and the relationship between EBV infection and MS onset during the period of active duty.
They found the risk of MS increased 32 times after infection with EBV but was unchanged after infection with other viruses.
Blood levels of neurofilament light chain, a biomarker of the nerve degeneration typical in MS, increased only after EBV infection.
The findings cannot be explained by any known risk factor for MS and suggest EBV as the leading cause of MS.
The team says that the delay between EBV infection and the onset of MS may be partially due to the disease’s symptoms being undetected during the earliest stages and partially due to the evolving relationship between EBV and the host’s immune system.
Currently, there is no way to effectively prevent or treat EBV infection, but an EBV vaccine or targeting the virus with EBV-specific antiviral drugs could ultimately prevent or cure MS.
If you care about brain health, please read studies about new light treatment that may slow down Alzheimer’s disease, and a new therapy for Alzheimer’s disease, and results showing these antioxidants could help reduce dementia risk.
The study was published in Science and conducted by Alberto Ascherio et al.
Copyright © 2022 Knowridge Science Report. All rights reserved.
